With existing pandemic funds dwindling and no new money from Congress in sight, the Biden administration is redistributing $10 billion from testing and other preparedness programs to ensure new COVID vaccines and existing treatments remain available this fall.
Why it matters: With Congress unwilling to approve new spending, the White House is making tough choices to avoid being caught short if new, more dangerous COVID variants emerge.